Reuters -- Epix Pharmaceuticals Inc (EPIX.O) said it may be forced to seek protection under the U.S. bankruptcy laws if it fails to restructure its obligations through an exchange offering of $100 million convertible notes. The biopharmaceutical company, which said last month that it auditors expressed doubt about its ability to continue as a going concern, offered to exchange the convertible senior notes due 2024 for common shares and a cash payment.
